New York, November 13 (Reuters/ PR Newswire ) – Co-founders Dr. Haley Abivardi and Dr. Goly Abivardi stated that they hope to reshape the future of dental care through a treatment method that does not require drilling teeth, with the goal of addressing tooth decay, the world's most prevalent non-communicable disease.

vVARDIS has solved a problem that affects millions of people. Dental caries impacts billions around the world, and dental anxiety prevents millions more from receiving the treatment they need. vVARDIS is a Swiss dental technology company dedicated to changing the way early-stage dental caries is treated. The company has introduced a new approach aimed at allowing patients to receive treatment earlier and more comfortably. Its flagship product, Curodont ® Repair Fluoride Plus, uses proprietary peptide technology to help repair early-stage dental caries by supporting the natural remineralization of tooth enamel – in simple terms, there's no need for drilling, no need for injections, and no need for fillings.

Cavities are one of the most common health problems worldwide. There are 2.5 billion people globally who suffer from untreated cavities. Nearly 90% of American adults have experienced cavities at some point. Around 73% of American adults say they are afraid of going to the dentist, and 21% avoid dental visits due to anxiety.

The story of shaping vVARDIS. For decades, treating early-stage cavities often meant waiting for the condition to worsen or simply filling the tooth. It took two founders 25 years to develop Curodont ® Repair Fluoride Plus, a treatment method that helps repair early-stage cavities before they develop into holes. Curodont ® enables dentists to treat early-stage cavities more easily and less stressfully. This technology has now treated over 2.5 million teeth and is available in more than 20% of dental clinics in the United States.

Click here to learn more about vVARDIS: https :// www.youtube.com / watch ?v= T1p9hUR5Glk